
Day 1 - November 24, 2010, Wednesday
Day of pharmaceutical technologies – ingredients and equipment
| 10.00-13.35 | Excipients and raw materials for pharmaceutical production |
| Moderator: Sergey Skvortsov, Elementoorganika (Russia), managing director | |
| 10.00-10.25 | Registration |
| 10.30-10.40 | Welcome addresses by organizers |
| 10.45-11.15 | Advantia: water-based film coating systems for pharmaceutical and nutritional products Olga Tyurina,ISP (USA), pharma sales engineer Abstract |
| 11.20-11.50 | Soluplus® – the innovative solubilizer for hot melt extrusion Andrey Afonin, BASF (Germany), Senior Sales Manager Abstract |
| 11.55-12.25 | Innovative emulsifier systems Tatiana Koshkina, CRODA (UK), regional sales manager Abstract |
| 12.30-13.00 | Modern excipients for direct pressing and wet granulation Alexey Prokopov, Merck (Germany), technical specialist Abstract |
| 13.05-13.20 | Problems of the development of API production in Russia Alexander Machula, BION (Russia), deputy director research and development Abstract |
| 13.25-13.55 | Networking Coffee break |
| 14.00-17.00 | Equipment and technologies for pharmaceutical production |
| Moderator: Jens Hoffmann, MediBalt (Latvia), managing director | |
| 14.00-14.20 | Implementation of GMP in Russia – current state Andrei Meshkovski,First Moscow State Medical University (Russia), assistant professor Abstract |
| 14.25-14.55 | Development of Glatt Fluid Bed Equipment from the beginning to "WS Combo" line Helmut Matzel, Glatt Ingenieurtechnik (Germany), sales engineer Abstract |
| 15.00-15.30 | Pharma equipment and wiped film technology for organic synthesis and biotechnology Gerhard Hoegl, GIG Karasek (Austria), sales & marketing director Abstract |
| 15.35-16.05 | Cleaning and Disinfection according EU-GMP & US-GMP guidelines Michael Richter, Ecolab (Germany), technical managing director Abstract |
| 16.10-16.40 | Equipment tenders - comparison of offers and evaluation Oleg Spitsky,NNE Pharmaplan (Russia), team leader GMP / validation Abstract |
| 16.45-17.00 | Closing remarks |